Fund Overview - The fund is named "Zhaoshang Zhongzheng Biotechnology Theme ETF" and was established on February 8, 2021, with a total fund share of 145,372,396.00 shares as of the report date [2][3]. - The fund aims to closely track the performance of the underlying index, minimizing tracking deviation and error through a full replication strategy [2][3]. Financial Performance - The fund reported a realized loss of approximately 8.98 million RMB and a profit of 5.37 million RMB for the reporting period from January 1 to June 30, 2025 [3][4]. - The weighted average net value profit rate was 7.21%, with a net asset value of approximately 71.41 million RMB at the end of the reporting period [3][4]. - The fund's net asset value per share was 0.4913 RMB, with a cumulative net value growth rate of -50.87% since inception [3][4]. Market Context - The underlying index, the Zhongzheng Biotechnology Theme Index, increased by 6.46% during the reporting period, while the fund's net value growth rate was 6.87% [7][8]. - The market showed active trading sentiment, supported by fiscal and monetary policies aimed at stabilizing growth and promoting high-quality development [7][8]. Investment Strategy - The fund employs a strategy that includes risk management through hedging with liquid and actively traded index futures, as well as participation in government bond futures to control systemic risks in the bond market [2][3]. - The fund's investment decisions are based on thorough analysis of macroeconomic conditions and the impact of domestic fiscal and monetary policies on the bond market [2][3]. Regulatory Compliance - The fund management strictly adheres to relevant laws and regulations, ensuring that all transactions are conducted in compliance with the fund contract and regulatory requirements [6][8]. - The fund has not experienced any significant abnormal trading behavior that could harm the interests of fund shareholders during the reporting period [6][8].